VANCE, US DELEGATION TO LAND IN ISLAMABAD WITHIN HOURS: NYP

Eli Lilly (Lly.N) is in advanced talks to acquire Kelonia Therapeutics for more than $2 billion.

Key News 1. NDRC: Promote increased oil and gas reserves and production, strengthen the role of coal and coal-fired power as a safety net. 2. NDRC issues the second batch of "major" construction projects for 2026. 3. CSRC: Clarifies that the National Social Security Fund and basic pension insurance fund can act as strategic investors, with the subscription ratio of strategic investors generally not less than 5%. 4. MIIT and other departments hold a symposium on the photovoltaic industry to deploy work related to regulating the competitive order of the photovoltaic industry. 5. Ministry of Agriculture and Rural Affairs holds a symposium on the development of the pig industry. 6. The upper limit of the size of the Beijing Stock Exchange 50 Index Fund will be increased. 7. Ministry of Finance and other departments: Adjust the scope of goods eligible for VAT and consumption tax refunds in the Pingtan Comprehensive Experimental Zone. Individual Stock News 1. CATL: Shareholder Lianhe Innovation plans to transfer 58 million shares through a price inquiry, accounting for 1.27% of the total share capital. 2. Shanghai Electric participates in the research and development of "gutter oil" converted into aviation fuel. 3. SDIC Intelligent: The company has built a full-chain AI security capability system. 4. Inspur Software: Net profit in 2025 was a loss of 267 million yuan, a year-on-year decrease of 2057.59%. 5. Northern Rare Earth: Net profit was 2.251 billion yuan, a year-on-year increase of 124.17%. 6. Huadian Engineering & Technology released 10 new technologies and products. 7. Sanan Optoelectronics: Terminated the acquisition of 100% equity in Lumileds Holding B.V. 8. China Nonferrous Metal Mining: The acquisition of 99.9004% equity in Raura has been completed. 9. Hikvision: The company still faces many uncertainties in its full-year operations and will respond cautiously. 10. Kanghong Pharmaceutical: Its subsidiary's KHN921 injection has received FDA approval to conduct clinical trials. 11. Ganzhao Optoelectronics: The company's 10G/25G products have completed sampling and are expected to generate formal orders and be delivered this year. 12. Liyuan Information: First-quarter net profit increased by 241% year-on-year, with significant growth in AI businesses such as optical modules and liquid cooling due to continued strong downstream demand. 13. Jiangxin Home Furnishings: We continue to monitor relevant US tax and tax refund policies; the specific application and actual impact on the company remain uncertain.